Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd > NOX BEGINS PROGRAM ON MARBAN BLOCK

<< Previous

Bullboard Posts

Next >>

Comment by clestoron Jan 16, 2013 10:07am

162 Views

Post# 20844357

RE: RE: RE: NOX BEGINS PROGRAM ON MARBAN BLOCK

https://www.niogold.com/projects/maps/Malartic-Block-Drill-Hole-Location.pdf

I believe the North Zone is shown on this map, but not labeled. It is just above the Norlartic zone and to the right/East of Kierens . . . in the bottom right corner of the map (Marban Block).

This sounds like high priority drilling that would definitely be part of phase III and keeps the team at NOX busy while ARZ sharpens its pencil

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages